EMEA (Europe, Middle East and Africa) Exosome Diagnostic and Therapeutic Market Report 2017

October 2017 | 111 pages | ID: E45A05F6196WEN
QYResearch

Abstracts

In this report, the EMEA Exosome Diagnostic and Therapeutic market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Exosome Diagnostic and Therapeutic for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Exosome Diagnostic and Therapeutic market competition by top manufacturers/players, with Exosome Diagnostic and Therapeutic sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Aethlon Medical
• Exosome Diagnostics
• NanoSomix
• Thermo Fisher Scientific
• Malvern Instruments
• System Biosciences
• NX Pharmagen
• Sistemic
• Capricor Therapeutics
• Exiqon
• 101BIO
• AMS Biotechnology Limited
• Therapeutic Solutions International
• ReNeuron Group
• Immune Therapy Holdings
• ExoCyte Therapeutics
• Cell Guidance Systems
• BioRegenerative Sciences
• Evomic Science
• Norgen Biotek

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Instrument
• Reagent
• Software

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Exosome Diagnostic and Therapeutic for each application, including

• Cancer Institute
• Hospital
• Diagnostic Center
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Exosome Diagnostic and Therapeutic Market Report 2017

1 EXOSOME DIAGNOSTIC AND THERAPEUTIC OVERVIEW

1.1 Product Overview and Scope of Exosome Diagnostic and Therapeutic
1.2 Classification of Exosome Diagnostic and Therapeutic
  1.2.1 EMEA Exosome Diagnostic and Therapeutic Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Exosome Diagnostic and Therapeutic Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Instrument
  1.2.4 Reagent
  1.2.5 Software
1.3 EMEA Exosome Diagnostic and Therapeutic Market by Application/End Users
  1.3.1 EMEA Exosome Diagnostic and Therapeutic Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Cancer Institute
  1.3.3 Hospital
  1.3.4 Diagnostic Center
  1.3.5 Others
1.4 EMEA Exosome Diagnostic and Therapeutic Market by Region
  1.4.1 EMEA Exosome Diagnostic and Therapeutic Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Exosome Diagnostic and Therapeutic (2012-2022)
  1.5.1 EMEA Exosome Diagnostic and Therapeutic Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Exosome Diagnostic and Therapeutic Revenue and Growth Rate (2012-2022)

2 EMEA EXOSOME DIAGNOSTIC AND THERAPEUTIC COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Exosome Diagnostic and Therapeutic Market Competition by Players/Manufacturers
  2.1.1 EMEA Exosome Diagnostic and Therapeutic Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Exosome Diagnostic and Therapeutic Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Exosome Diagnostic and Therapeutic Sale Price by Players (2012-2017)
2.2 EMEA Exosome Diagnostic and Therapeutic (Volume and Value) by Type/Product Category
  2.2.1 EMEA Exosome Diagnostic and Therapeutic Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Exosome Diagnostic and Therapeutic Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Exosome Diagnostic and Therapeutic Sale Price by Type (2012-2017)
2.3 EMEA Exosome Diagnostic and Therapeutic (Volume) by Application
2.4 EMEA Exosome Diagnostic and Therapeutic (Volume and Value) by Region
  2.4.1 EMEA Exosome Diagnostic and Therapeutic Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Exosome Diagnostic and Therapeutic Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Exosome Diagnostic and Therapeutic Sales Price by Region (2012-2017)

3 EUROPE EXOSOME DIAGNOSTIC AND THERAPEUTIC (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Exosome Diagnostic and Therapeutic Sales and Value (2012-2017)
  3.1.1 Europe Exosome Diagnostic and Therapeutic Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Exosome Diagnostic and Therapeutic Revenue and Growth Rate (2012-2017)
3.2 Europe Exosome Diagnostic and Therapeutic Sales and Market Share by Type
3.3 Europe Exosome Diagnostic and Therapeutic Sales and Market Share by Application
3.4 Europe Exosome Diagnostic and Therapeutic Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Exosome Diagnostic and Therapeutic Sales Volume by Countries (2012-2017)
  3.4.2 Europe Exosome Diagnostic and Therapeutic Revenue by Countries (2012-2017)
  3.4.3 Germany Exosome Diagnostic and Therapeutic Sales and Growth Rate (2012-2017)
  3.4.4 France Exosome Diagnostic and Therapeutic Sales and Growth Rate (2012-2017)
  3.4.5 UK Exosome Diagnostic and Therapeutic Sales and Growth Rate (2012-2017)
  3.4.6 Russia Exosome Diagnostic and Therapeutic Sales and Growth Rate (2012-2017)
  3.4.7 Italy Exosome Diagnostic and Therapeutic Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Exosome Diagnostic and Therapeutic Sales and Growth Rate (2012-2017)

4 MIDDLE EAST EXOSOME DIAGNOSTIC AND THERAPEUTIC (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Exosome Diagnostic and Therapeutic Sales and Value (2012-2017)
  4.1.1 Middle East Exosome Diagnostic and Therapeutic Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Exosome Diagnostic and Therapeutic Revenue and Growth Rate (2012-2017)
4.2 Middle East Exosome Diagnostic and Therapeutic Sales and Market Share by Type
4.3 Middle East Exosome Diagnostic and Therapeutic Sales and Market Share by Application
4.4 Middle East Exosome Diagnostic and Therapeutic Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Exosome Diagnostic and Therapeutic Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Exosome Diagnostic and Therapeutic Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Exosome Diagnostic and Therapeutic Sales and Growth Rate (2012-2017)
  4.4.4 Israel Exosome Diagnostic and Therapeutic Sales and Growth Rate (2012-2017)
  4.4.5 UAE Exosome Diagnostic and Therapeutic Sales and Growth Rate (2012-2017)
  4.4.6 Iran Exosome Diagnostic and Therapeutic Sales and Growth Rate (2012-2017)

5 AFRICA EXOSOME DIAGNOSTIC AND THERAPEUTIC (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Exosome Diagnostic and Therapeutic Sales and Value (2012-2017)
  5.1.1 Africa Exosome Diagnostic and Therapeutic Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Exosome Diagnostic and Therapeutic Revenue and Growth Rate (2012-2017)
5.2 Africa Exosome Diagnostic and Therapeutic Sales and Market Share by Type
5.3 Africa Exosome Diagnostic and Therapeutic Sales and Market Share by Application
5.4 Africa Exosome Diagnostic and Therapeutic Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Exosome Diagnostic and Therapeutic Sales Volume by Countries (2012-2017)
  5.4.2 Africa Exosome Diagnostic and Therapeutic Revenue by Countries (2012-2017)
  5.4.3 South Africa Exosome Diagnostic and Therapeutic Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Exosome Diagnostic and Therapeutic Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Exosome Diagnostic and Therapeutic Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Exosome Diagnostic and Therapeutic Sales and Growth Rate (2012-2017)

6 EMEA EXOSOME DIAGNOSTIC AND THERAPEUTIC MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Aethlon Medical
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Exosome Diagnostic and Therapeutic Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Aethlon Medical Exosome Diagnostic and Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Exosome Diagnostics
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Exosome Diagnostic and Therapeutic Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Exosome Diagnostics Exosome Diagnostic and Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 NanoSomix
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Exosome Diagnostic and Therapeutic Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 NanoSomix Exosome Diagnostic and Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Thermo Fisher Scientific
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Exosome Diagnostic and Therapeutic Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Thermo Fisher Scientific Exosome Diagnostic and Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Malvern Instruments
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Exosome Diagnostic and Therapeutic Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Malvern Instruments Exosome Diagnostic and Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 System Biosciences
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Exosome Diagnostic and Therapeutic Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 System Biosciences Exosome Diagnostic and Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 NX Pharmagen
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Exosome Diagnostic and Therapeutic Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 NX Pharmagen Exosome Diagnostic and Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Sistemic
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Exosome Diagnostic and Therapeutic Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Sistemic Exosome Diagnostic and Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Capricor Therapeutics
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Exosome Diagnostic and Therapeutic Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Capricor Therapeutics Exosome Diagnostic and Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Exiqon
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Exosome Diagnostic and Therapeutic Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Exiqon Exosome Diagnostic and Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 101BIO
6.12 AMS Biotechnology Limited
6.13 Therapeutic Solutions International
6.14 ReNeuron Group
6.15 Immune Therapy Holdings
6.16 ExoCyte Therapeutics
6.17 Cell Guidance Systems
6.18 BioRegenerative Sciences
6.19 Evomic Science
6.20 Norgen Biotek

7 EXOSOME DIAGNOSTIC AND THERAPEUTIC MANUFACTURING COST ANALYSIS

7.1 Exosome Diagnostic and Therapeutic Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Exosome Diagnostic and Therapeutic

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Exosome Diagnostic and Therapeutic Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Exosome Diagnostic and Therapeutic Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FORECAST (2017-2022)

11.1 EMEA Exosome Diagnostic and Therapeutic Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Exosome Diagnostic and Therapeutic Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Exosome Diagnostic and Therapeutic Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Exosome Diagnostic and Therapeutic Price and Trend Forecast (2017-2022)
11.2 EMEA Exosome Diagnostic and Therapeutic Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Exosome Diagnostic and Therapeutic Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Exosome Diagnostic and Therapeutic Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Exosome Diagnostic and Therapeutic Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Exosome Diagnostic and Therapeutic Sales Forecast by Type (2017-2022)
11.7 EMEA Exosome Diagnostic and Therapeutic Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Exosome Diagnostic and Therapeutic
Figure EMEA Exosome Diagnostic and Therapeutic Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Exosome Diagnostic and Therapeutic Sales Volume Market Share by Type (Product Category) in 2016
Figure Instrument Product Picture
Figure Reagent Product Picture
Figure Software Product Picture
Figure EMEA Exosome Diagnostic and Therapeutic Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Exosome Diagnostic and Therapeutic by Application in 2016
Figure Cancer Institute Examples
Table Key Downstream Customer in Cancer Institute
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Diagnostic Center Examples
Table Key Downstream Customer in Diagnostic Center
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Exosome Diagnostic and Therapeutic Market Size (Million USD) by Region (2012-2022)
Figure Europe Exosome Diagnostic and Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Exosome Diagnostic and Therapeutic Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Exosome Diagnostic and Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Exosome Diagnostic and Therapeutic Revenue (Million USD) Status and Forecast by Countries
Figure Africa Exosome Diagnostic and Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Exosome Diagnostic and Therapeutic Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Exosome Diagnostic and Therapeutic Sales Volume and Growth Rate (2012-2022)
Figure EMEA Exosome Diagnostic and Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Exosome Diagnostic and Therapeutic Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Exosome Diagnostic and Therapeutic Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Exosome Diagnostic and Therapeutic Sales Share by Players (2012-2017)
Figure 2016 Exosome Diagnostic and Therapeutic Sales Share by Players
Figure 2017 Exosome Diagnostic and Therapeutic Sales Share by Players
Figure EMEA Exosome Diagnostic and Therapeutic Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Exosome Diagnostic and Therapeutic Revenue (Million USD) by Players (2012-2017)
Table EMEA Exosome Diagnostic and Therapeutic Revenue Share by Players (2012-2017)
Table 2016 EMEA Exosome Diagnostic and Therapeutic Revenue Share by Players
Table 2017 EMEA Exosome Diagnostic and Therapeutic Revenue Share by Players
Table EMEA Exosome Diagnostic and Therapeutic Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Exosome Diagnostic and Therapeutic Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Exosome Diagnostic and Therapeutic Sales Share by Type (2012-2017)
Figure Sales Market Share of Exosome Diagnostic and Therapeutic by Type (2012-2017)
Figure EMEA Exosome Diagnostic and Therapeutic Sales Market Share by Type (2012-2017)
Table EMEA Exosome Diagnostic and Therapeutic Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Exosome Diagnostic and Therapeutic Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Exosome Diagnostic and Therapeutic by Type in 2016
Table EMEA Exosome Diagnostic and Therapeutic Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Exosome Diagnostic and Therapeutic Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Exosome Diagnostic and Therapeutic Sales Share by Application (2012-2017)
Figure Sales Market Share of Exosome Diagnostic and Therapeutic by Application (2012-2017)
Figure EMEA Exosome Diagnostic and Therapeutic Sales Market Share by Application in 2016
Table EMEA Exosome Diagnostic and Therapeutic Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Exosome Diagnostic and Therapeutic Sales Share by Region (2012-2017)
Figure Sales Market Share of Exosome Diagnostic and Therapeutic by Region (2012-2017)
Figure EMEA Exosome Diagnostic and Therapeutic Sales Market Share in 2016
Table EMEA Exosome Diagnostic and Therapeutic Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Exosome Diagnostic and Therapeutic Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Exosome Diagnostic and Therapeutic by Region (2012-2017)
Figure EMEA Exosome Diagnostic and Therapeutic Revenue Market Share Regions in 2016
Table EMEA Exosome Diagnostic and Therapeutic Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Exosome Diagnostic and Therapeutic Revenue and Growth Rate (2012-2017)
Table Europe Exosome Diagnostic and Therapeutic Sales (K Units) by Type (2012-2017)
Table Europe Exosome Diagnostic and Therapeutic Market Share by Type (2012-2017)
Figure Europe Exosome Diagnostic and Therapeutic Market Share by Type in 2016
Table Europe Exosome Diagnostic and Therapeutic Sales (K Units) by Application (2012-2017)
Table Europe Exosome Diagnostic and Therapeutic Market Share by Application (2012-2017)
Figure Europe Exosome Diagnostic and Therapeutic Market Share by Application in 2016
Table Europe Exosome Diagnostic and Therapeutic Sales (K Units) by Countries (2012-2017)
Table Europe Exosome Diagnostic and Therapeutic Sales Market Share by Countries (2012-2017)
Figure Europe Exosome Diagnostic and Therapeutic Sales Market Share by Countries (2012-2017)
Figure Europe Exosome Diagnostic and Therapeutic Sales Market Share by Countries in 2016
Table Europe Exosome Diagnostic and Therapeutic Revenue (Million USD) by Countries (2012-2017)
Table Europe Exosome Diagnostic and Therapeutic Revenue Market Share by Countries (2012-2017)
Figure Europe Exosome Diagnostic and Therapeutic Revenue Market Share by Countries (2012-2017)
Figure Europe Exosome Diagnostic and Therapeutic Revenue Market Share by Countries in 2016
Figure Germany Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure France Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure UK Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Exosome Diagnostic and Therapeutic Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Exosome Diagnostic and Therapeutic Sales (K Units) by Type (2012-2017)
Table Middle East Exosome Diagnostic and Therapeutic Market Share by Type (2012-2017)
Figure Middle East Exosome Diagnostic and Therapeutic Market Share by Type (2012-2017)
Table Middle East Exosome Diagnostic and Therapeutic Sales (K Units) by Applications (2012-2017)
Table Middle East Exosome Diagnostic and Therapeutic Market Share by Applications (2012-2017)
Figure Middle East Exosome Diagnostic and Therapeutic Sales Market Share by Application in 2016
Table Middle East Exosome Diagnostic and Therapeutic Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Exosome Diagnostic and Therapeutic Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Exosome Diagnostic and Therapeutic Sales Volume Market Share by Countries in 2016
Table Middle East Exosome Diagnostic and Therapeutic Revenue (Million USD) by Countries (2012-2017)
Table Middle East Exosome Diagnostic and Therapeutic Revenue Market Share by Countries (2012-2017)
Figure Middle East Exosome Diagnostic and Therapeutic Revenue Market Share by Countries (2012-2017)
Figure Middle East Exosome Diagnostic and Therapeutic Revenue Market Share by Countries in 2016
Figure Saudi Arabia Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Exosome Diagnostic and Therapeutic Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Exosome Diagnostic and Therapeutic Sales (K Units) by Type (2012-2017)
Table Africa Exosome Diagnostic and Therapeutic Sales Market Share by Type (2012-2017)
Figure Africa Exosome Diagnostic and Therapeutic Sales Market Share by Type (2012-2017)
Figure Africa Exosome Diagnostic and Therapeutic Sales Market Share by Type in 2016
Table Africa Exosome Diagnostic and Therapeutic Sales (K Units) by Application (2012-2017)
Table Africa Exosome Diagnostic and Therapeutic Sales Market Share by Application (2012-2017)
Figure Africa Exosome Diagnostic and Therapeutic Sales Market Share by Application (2012-2017)
Table Africa Exosome Diagnostic and Therapeutic Sales Volume (K Units) by Countries (2012-2017)
Table Africa Exosome Diagnostic and Therapeutic Sales Market Share by Countries (2012-2017)
Figure Africa Exosome Diagnostic and Therapeutic Sales Market Share by Countries (2012-2017)
Figure Africa Exosome Diagnostic and Therapeutic Sales Market Share by Countries in 2016
Table Africa Exosome Diagnostic and Therapeutic Revenue (Million USD) by Countries (2012-2017)
Table Africa Exosome Diagnostic and Therapeutic Revenue Market Share by Countries (2012-2017)
Figure Africa Exosome Diagnostic and Therapeutic Revenue Market Share by Countries (2012-2017)
Figure Africa Exosome Diagnostic and Therapeutic Revenue Market Share by Countries in 2016
Figure South Africa Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Table Aethlon Medical Exosome Diagnostic and Therapeutic Basic Information List
Table Aethlon Medical Exosome Diagnostic and Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Aethlon Medical Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Aethlon Medical Exosome Diagnostic and Therapeutic Sales Market Share in EMEA (2012-2017)
Figure Aethlon Medical Exosome Diagnostic and Therapeutic Revenue Market Share in EMEA (2012-2017)
Table Exosome Diagnostics Exosome Diagnostic and Therapeutic Basic Information List
Table Exosome Diagnostics Exosome Diagnostic and Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Exosome Diagnostics Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Exosome Diagnostics Exosome Diagnostic and Therapeutic Sales Market Share in EMEA (2012-2017)
Figure Exosome Diagnostics Exosome Diagnostic and Therapeutic Revenue Market Share in EMEA (2012-2017)
Table NanoSomix Exosome Diagnostic and Therapeutic Basic Information List
Table NanoSomix Exosome Diagnostic and Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure NanoSomix Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure NanoSomix Exosome Diagnostic and Therapeutic Sales Market Share in EMEA (2012-2017)
Figure NanoSomix Exosome Diagnostic and Therapeutic Revenue Market Share in EMEA (2012-2017)
Table Thermo Fisher Scientific Exosome Diagnostic and Therapeutic Basic Information List
Table Thermo Fisher Scientific Exosome Diagnostic and Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Thermo Fisher Scientific Exosome Diagnostic and Therapeutic Sales Market Share in EMEA (2012-2017)
Figure Thermo Fisher Scientific Exosome Diagnostic and Therapeutic Revenue Market Share in EMEA (2012-2017)
Table Malvern Instruments Exosome Diagnostic and Therapeutic Basic Information List
Table Malvern Instruments Exosome Diagnostic and Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Malvern Instruments Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Malvern Instruments Exosome Diagnostic and Therapeutic Sales Market Share in EMEA (2012-2017)
Figure Malvern Instruments Exosome Diagnostic and Therapeutic Revenue Market Share in EMEA (2012-2017)
Table System Biosciences Exosome Diagnostic and Therapeutic Basic Information List
Table System Biosciences Exosome Diagnostic and Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure System Biosciences Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure System Biosciences Exosome Diagnostic and Therapeutic Sales Market Share in EMEA (2012-2017)
Figure System Biosciences Exosome Diagnostic and Therapeutic Revenue Market Share in EMEA (2012-2017)
Table NX Pharmagen Exosome Diagnostic and Therapeutic Basic Information List
Table NX Pharmagen Exosome Diagnostic and Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure NX Pharmagen Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure NX Pharmagen Exosome Diagnostic and Therapeutic Sales Market Share in EMEA (2012-2017)
Figure NX Pharmagen Exosome Diagnostic and Therapeutic Revenue Market Share in EMEA (2012-2017)
Table Sistemic Exosome Diagnostic and Therapeutic Basic Information List
Table Sistemic Exosome Diagnostic and Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sistemic Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Sistemic Exosome Diagnostic and Therapeutic Sales Market Share in EMEA (2012-2017)
Figure Sistemic Exosome Diagnostic and Therapeutic Revenue Market Share in EMEA (2012-2017)
Table Capricor Therapeutics Exosome Diagnostic and Therapeutic Basic Information List
Table Capricor Therapeutics Exosome Diagnostic and Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Capricor Therapeutics Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Capricor Therapeutics Exosome Diagnostic and Therapeutic Sales Market Share in EMEA (2012-2017)
Figure Capricor Therapeutics Exosome Diagnostic and Therapeutic Revenue Market Share in EMEA (2012-2017)
Table Exiqon Exosome Diagnostic and Therapeutic Basic Information List
Table Exiqon Exosome Diagnostic and Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Exiqon Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate (2012-2017)
Figure Exiqon Exosome Diagnostic and Therapeutic Sales Market Share in EMEA (2012-2017)
Figure Exiqon Exosome Diagnostic and Therapeutic Revenue Market Share in EMEA (2012-2017)
Table 101BIO Exosome Diagnostic and Therapeutic Basic Information List
Table AMS Biotechnology Limited Exosome Diagnostic and Therapeutic Basic Information List
Table Therapeutic Solutions International Exosome Diagnostic and Therapeutic Basic Information List
Table ReNeuron Group Exosome Diagnostic and Therapeutic Basic Information List
Table Immune Therapy Holdings Exosome Diagnostic and Therapeutic Basic Information List
Table ExoCyte Therapeutics Exosome Diagnostic and Therapeutic Basic Information List
Table Cell Guidance Systems Exosome Diagnostic and Therapeutic Basic Information List
Table BioRegenerative Sciences Exosome Diagnostic and Therapeutic Basic Information List
Table Evomic Science Exosome Diagnostic and Therapeutic Basic Information List
Table Norgen Biotek Exosome Diagnostic and Therapeutic Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Exosome Diagnostic and Therapeutic
Figure Manufacturing Process Analysis of Exosome Diagnostic and Therapeutic
Figure Exosome Diagnostic and Therapeutic Industrial Chain Analysis
Table Raw Materials Sources of Exosome Diagnostic and Therapeutic Major Manufacturers in 2016
Table Major Buyers of Exosome Diagnostic and Therapeutic
Table Distributors/Traders List
Figure EMEA Exosome Diagnostic and Therapeutic Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Exosome Diagnostic and Therapeutic Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Exosome Diagnostic and Therapeutic Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Exosome Diagnostic and Therapeutic Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Exosome Diagnostic and Therapeutic Sales Market Share Forecast by Region (2017-2022)
Table EMEA Exosome Diagnostic and Therapeutic Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Exosome Diagnostic and Therapeutic Revenue Market Share Forecast by Region (2017-2022)
Table Europe Exosome Diagnostic and Therapeutic Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Exosome Diagnostic and Therapeutic Sales Market Share Forecast by Countries (2017-2022)
Table Europe Exosome Diagnostic and Therapeutic Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Exosome Diagnostic and Therapeutic Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Exosome Diagnostic and Therapeutic Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Exosome Diagnostic and Therapeutic Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Exosome Diagnostic and Therapeutic Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Exosome Diagnostic and Therapeutic Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Exosome Diagnostic and Therapeutic Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Exosome Diagnostic and Therapeutic Sales Market Share Forecast by Countries (2017-2022)
Table Africa Exosome Diagnostic and Therapeutic Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Exosome Diagnostic and Therapeutic Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Exosome Diagnostic and Therapeutic Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Exosome Diagnostic and Therapeutic Sales Market Share Forecast by Type (2017-2022)
Table EMEA Exosome Diagnostic and Therapeutic Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Exosome Diagnostic and Therapeutic Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources